Nihon Rinsho Geka Gakkai Zasshi (Journal of Japan Surgical Association)
Online ISSN : 1882-5133
Print ISSN : 1345-2843
ISSN-L : 1345-2843
CLINICAL STUDIES
A long-term survivor of recurrent bile duct cancer treated with bypass surgery and gemcitabine, ts-1 administration
Taku MATSUMOTOTetsuo AJIKITsunenori FUJITAShiro TAKASEYasuyuki SUZUKIYoshikazu KURODA
Author information
JOURNAL FREE ACCESS

2008 Volume 69 Issue 3 Pages 662-665

Details
Abstract
A 70-year-old man with bile duct cancer underwent pancreatico-duodenectomy in May, 2002. Pathological findings revealed lymph node metastasis and tumor infiltration to the pancreas head. Twenty-three months after surgery, a local recurrence was pointed out and he was treated with gemcitabine (GEM) with his informed consent. However, repeated fever frequently occurred as of January 2005, and abdominal CT revealed the increased massive recurrent tumor and dilated jejunal loop. Since we diagnosed the patient as jejunal loop obstruction due to recurrent tumor, we performed side to side anastmosis of the afferent and efferent loop. After this operation, he underwent treatment with TS-1 for 17 consecutive months. Because ascites increased and ingestion became difficult, the treatment was changed to best supportive care, and he died at April 2007, 58 months after his first operation.
Content from these authors
© 2008 Japan Surgical Association
Previous article Next article
feedback
Top